Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit?
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
There is exponential interest in non-alcoholic fatty liver disease (NAFLD) as a cause of chronic liver disease in the last decade [1]. The epidemic of obesity due to changes in life style and nutritional habits in Western countries has greatly contributed to the rapid increase in prevalence of NAFLD. In addition to obesity, NAFLD is strongly associated with diabetes mellitus and insulin resistance that are believed to be a consequence of low physical activity and increased fat mass as well as the metabolic syndrome [2,3].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lim, S., Kim, J. H., Yoon, J. W., Kang, S. M., Choi, S. H., Park, Y. J., Kim, K. W., Lim, J. Y., Park, K. S., & Jang, H. C. (2010) · Diabetes Care · doi:10.2337/dc10-0107 · Cited by 588 · cited 1×
“By analyzing the same database, previous studies had shown that, during aging, the increase in fat mass and the decrease in muscle mass resulted in an increase in metabolic disorders [5].”
MethodPrevalence and Determinant Factors of Sarcopenia in Patients With Type 2 Diabetes
Kim, T. N., Park, M. S., Yang, S. J., Yoo, H. J., Kang, H. J., Song, W., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., et al. (2010) · Diabetes Care · doi:10.2337/dc09-2310 · Cited by 585
Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis
Seldin, M. M., Peterson, J. M., Byerly, M. S., Wei, Z., & Wong, G. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.336834 · Cited by 406
Hong, H. C., Hwang, S. Y., Choi, H. Y., Yoo, H. J., Seo, J. A., Kim, S. G., Kim, N. H., Baik, S. H., Choi, D. S., & Choi, K. M. (2014) · Hepatology · doi:10.1002/hep.26716 · Cited by 385 · cited 1×
“The first observation that a reduction in muscle tissue (better known as sarcopenia) could be involved in NAFLD came from the Korean Sarcopenic Obesity Study [4].”
BackgroundIrisin in patients with nonalcoholic fatty liver disease
Polyzos, S. A., Kountouras, J., Anastasilakis, A. D., Geladari, E. V., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2013.09.013 · Cited by 215
Bredella, M. A., Ghomi, R. H., Thomas, B. J., Torriani, M., Brick, D. J., Gerweck, A. V., Misra, M., Klibanski, A., & Miller, K. K. (2010) · Obesity · doi:10.1038/oby.2010.5 · Cited by 201
Zhang, C., McFarlane, C., Lokireddy, S., Bonala, S., Ge, X., Masuda, S., Gluckman, P. D., Sharma, M., & Kambadur, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2079-7 · Cited by 158 · cited 1×
“Blocking myostatin not only increases muscle mass but also protects mice from fatty liver and improves insulin resistance [16,17].”
Background
Cited by
Bo, T., Gao, L., Yao, Z., Shao, S., Wang, X., Proud, C. G., & Zhao, J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.006 · Cited by 293
Bhanji, R. A., Narayanan, P., Allen, A. M., Malhi, H., & Watt, K. D. (2017) · Hepatology · doi:10.1002/hep.29420 · Cited by 258
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review
Armandi, A., Rosso, C., Caviglia, G. P., Ribaldone, D. G., & Bugianesi, E. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.716533 · Cited by 48
Sarcopenic obesity in fatty liver
Merli, M., Lattanzi, B., & Aprile, F. (2019) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000558 · Cited by 48
Self-citationNonalcoholic fatty liver disease and sarcopenia: Where do we stand?
Mikolasevic, I., Pavic, T., Filipec Kanizaj, T., Bender, D. V., Domislovic, V., & Krznaric, Z. (2020) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2020/8859719 · Cited by 30
Metadata
- Authors
- Merli, M., & Dasarathy, S.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 63
- Issue
- 2
- Pages
- 309-311
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W1565594933
- Cited by
- 51
- References
- 7
- FWCI
- 2.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit? https://app.cochat.ai/papers/10.1016/j.jhep.2015.05.014
- The paper
- Merli, M., & Dasarathy, S. (2015). Sarcopenia in non-alcoholic fatty liver disease: Targeting the real culprit? Journal of Hepatology. https://doi.org/10.1016/j.jhep.2015.05.014
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.